Thor Mining (LON:THR) - All eyes on Jetrea launch
Oct 25th 2012 - Edison Investment Research today published a report on Thor Mining (THR.L, LSE:THR, LON:THR) entitled "All Eyes On Jetrea Launch". In summary, the report says:
Jetrea’s US approval is a significant milestone for ThromboGenics and its recent share price performance reflects this. With a first-pass FDA endorsement in the broadest possible indication and EU approval due in Q113, shares are trading at c 3% off an all-time high. Investor interest should now turn to the US launch, due in January 2013. Jetrea’s pricing could, however, offer near-term upside, with suggestions that prior guidance could be overly conservative.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »
